Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITRAG: Itraconazole Prophylaxis for IFIs in GVHD
NCT01282879Phase 4Terminated
- Sponsor
- Samsung Medical Center
- Start
- Dec 2009
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of itraconazole in invasive fungal infection (IFI), sponsored by Samsung Medical Center. Started Dec 2009; status: terminated.
02
Drugs
itraconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT01282879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01282879.